This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Erythropoietin Drug Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Drug Class (Biologics, Biosimilars); Product (Epoetin-Alfa, Epoetin-beta, Darbepoetin-alfa, Others); Application (Cancer, Hematology, Renal diseases, Neurology) and Geography
Erythropoietin is a hormone which is basically produced by the kidneys helping in production of red blood cells, which carry oxygen from the lungs to rest of the body. Erythropoietin drugs are injectable drugs used to cure anemia and other such diseases.
MARKET DYNAMICS
The Erythropoietin (EPO) Drugs market is anticipated to grow in the forecast period owing to driving factors such as rising number of patients suffering from anemia, favorable reimbursements and increasing commercialization of EPO biosimilars and rising incidence of Chronic Kidney Diseases.
MARKET SCOPE
The "Global Erythropoietin (EPO) Drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Erythropoietin (EPO) Drugs market with detailed market segmentation by Drug, Product, Application and geography. The global Erythropoietin (EPO) Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Erythropoietin (EPO) Drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Erythropoietin (EPO) Drugs market is segmented on the basis of Drug, Product and Application. Based on Drugs the market is segmented into Biologics, Biosimilars. Based on Product the market is segmented into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa. Based on Application the market is segmented into Cancer, Hematology, Renal Disease, Neurology.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Erythropoietin (EPO) Drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Erythropoietin (EPO) Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region. The report analyzes factors affecting Erythropoietin (EPO) Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Erythropoietin (EPO) Drugs market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the Erythropoietin (EPO) Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Erythropoietin (EPO) Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Erythropoietin (EPO) Drugs in the global market. Below mentioned is the list of few companies engaged in the Erythropoietin (EPO) Drugs market. The report also includes the profiles of key Erythropoietin (EPO) Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Johnson & Johnson
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
Amgen, Inc
F. Hoffman-La Roche Ltd.
LG Life Sciences Ltd.
Biocon Limited
Intas Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Erythropoietin (EPO) Drugs Market - By Drug 1.3.2 Erythropoietin (EPO) Drugs Market - By Product 1.3.3 Erythropoietin (EPO) Drugs Market - By Application 1.3.4 Erythropoietin (EPO) Drugs Market - By Region 1.3.4.1 By Country 2. KEY TAKEAWAYS 3. RESEARCH METHODOLOGY 4. ERYTHROPOIETIN (EPO) DRUGS MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS 5. ERYTHROPOIETIN (EPO) DRUGS MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC 6. ERYTHROPOIETIN (EPO) DRUGS MARKET - GLOBAL MARKET ANALYSIS 6.1. ERYTHROPOIETIN (EPO) DRUGS - GLOBAL MARKET OVERVIEW 6.2. ERYTHROPOIETIN (EPO) DRUGS - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE 7. ERYTHROPOIETIN (EPO) DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG 7.1. OVERVIEW 7.2. DRUG MARKET FORECASTS AND ANALYSIS 7.3. BIOLOGICS 7.3.1. Overview 7.3.2. Biologics Market Forecast and Analysis 7.4. BIOSIMILARS 7.4.1. Overview 7.4.2. Biosimilars Market Forecast and Analysis 8. ERYTHROPOIETIN (EPO) DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT 8.1. OVERVIEW 8.2. PRODUCT MARKET FORECASTS AND ANALYSIS 8.3. EPOETIN-ALFA 8.3.1. Overview 8.3.2. Epoetin-alfa Market Forecast and Analysis 8.4. EPOETIN-BETA 8.4.1. Overview 8.4.2. Epoetin-beta Market Forecast and Analysis 8.5. DARBEPOETIN-ALFA 8.5.1. Overview 8.5.2. Darbepoetin-alfa Market Forecast and Analysis 9. ERYTHROPOIETIN (EPO) DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION 9.1. OVERVIEW 9.2. APPLICATION MARKET FORECASTS AND ANALYSIS 9.3. CANCER 9.3.1. Overview 9.3.2. Cancer Market Forecast and Analysis 9.4. HEMATOLOGY 9.4.1. Overview 9.4.2. Hematology Market Forecast and Analysis 9.5. RENAL DISEASE 9.5.1. Overview 9.5.2. Renal Disease Market Forecast and Analysis 9.6. NEUROLOGY 9.6.1. Overview 9.6.2. Neurology Market Forecast and Analysis 10. ERYTHROPOIETIN (EPO) DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America Erythropoietin (EPO) Drugs Market Overview 10.1.2 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis 10.1.3 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug 10.1.4 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product 10.1.5 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application 10.1.6 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries 10.1.6.1 United States Erythropoietin (EPO) Drugs Market 10.1.6.1.1 United States Erythropoietin (EPO) Drugs Market by Drug 10.1.6.1.2 United States Erythropoietin (EPO) Drugs Market by Product 10.1.6.1.3 United States Erythropoietin (EPO) Drugs Market by Application 10.1.6.2 Canada Erythropoietin (EPO) Drugs Market 10.1.6.2.1 Canada Erythropoietin (EPO) Drugs Market by Drug 10.1.6.2.2 Canada Erythropoietin (EPO) Drugs Market by Product 10.1.6.2.3 Canada Erythropoietin (EPO) Drugs Market by Application 10.1.6.3 Mexico Erythropoietin (EPO) Drugs Market 10.1.6.3.1 Mexico Erythropoietin (EPO) Drugs Market by Drug 10.1.6.3.2 Mexico Erythropoietin (EPO) Drugs Market by Product 10.1.6.3.3 Mexico Erythropoietin (EPO) Drugs Market by Application 10.1.6.4 US Erythropoietin (EPO) Drugs Market 10.1.6.4.1 US Erythropoietin (EPO) Drugs Market by Drug 10.1.6.4.2 US Erythropoietin (EPO) Drugs Market by Product 10.1.6.4.3 US Erythropoietin (EPO) Drugs Market by Application 10.2. EUROPE 10.2.1 Europe Erythropoietin (EPO) Drugs Market Overview 10.2.2 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis 10.2.3 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug 10.2.4 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product 10.2.5 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application 10.2.6 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries 10.2.6.1 Germany Erythropoietin (EPO) Drugs Market 10.2.6.1.1 Germany Erythropoietin (EPO) Drugs Market by Drug 10.2.6.1.2 Germany Erythropoietin (EPO) Drugs Market by Product 10.2.6.1.3 Germany Erythropoietin (EPO) Drugs Market by Application 10.2.6.2 France Erythropoietin (EPO) Drugs Market 10.2.6.2.1 France Erythropoietin (EPO) Drugs Market by Drug 10.2.6.2.2 France Erythropoietin (EPO) Drugs Market by Product 10.2.6.2.3 France Erythropoietin (EPO) Drugs Market by Application 10.2.6.3 Italy Erythropoietin (EPO) Drugs Market 10.2.6.3.1 Italy Erythropoietin (EPO) Drugs Market by Drug 10.2.6.3.2 Italy Erythropoietin (EPO) Drugs Market by Product 10.2.6.3.3 Italy Erythropoietin (EPO) Drugs Market by Application 10.2.6.4 Spain Erythropoietin (EPO) Drugs Market 10.2.6.4.1 Spain Erythropoietin (EPO) Drugs Market by Drug 10.2.6.4.2 Spain Erythropoietin (EPO) Drugs Market by Product 10.2.6.4.3 Spain Erythropoietin (EPO) Drugs Market by Application 10.2.6.5 United Kingdom Erythropoietin (EPO) Drugs Market 10.2.6.5.1 United Kingdom Erythropoietin (EPO) Drugs Market by Drug 10.2.6.5.2 United Kingdom Erythropoietin (EPO) Drugs Market by Product 10.2.6.5.3 United Kingdom Erythropoietin (EPO) Drugs Market by Application 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Overview 10.3.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis 10.3.3 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug 10.3.4 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product 10.3.5 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application 10.3.6 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries 10.3.6.1 Australia Erythropoietin (EPO) Drugs Market 10.3.6.1.1 Australia Erythropoietin (EPO) Drugs Market by Drug 10.3.6.1.2 Australia Erythropoietin (EPO) Drugs Market by Product 10.3.6.1.3 Australia Erythropoietin (EPO) Drugs Market by Application 10.3.6.2 China Erythropoietin (EPO) Drugs Market 10.3.6.2.1 China Erythropoietin (EPO) Drugs Market by Drug 10.3.6.2.2 China Erythropoietin (EPO) Drugs Market by Product 10.3.6.2.3 China Erythropoietin (EPO) Drugs Market by Application 10.3.6.3 India Erythropoietin (EPO) Drugs Market 10.3.6.3.1 India Erythropoietin (EPO) Drugs Market by Drug 10.3.6.3.2 India Erythropoietin (EPO) Drugs Market by Product 10.3.6.3.3 India Erythropoietin (EPO) Drugs Market by Application 10.3.6.4 Japan Erythropoietin (EPO) Drugs Market 10.3.6.4.1 Japan Erythropoietin (EPO) Drugs Market by Drug 10.3.6.4.2 Japan Erythropoietin (EPO) Drugs Market by Product 10.3.6.4.3 Japan Erythropoietin (EPO) Drugs Market by Application 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa Erythropoietin (EPO) Drugs Market Overview 10.4.2 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis 10.4.3 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug 10.4.4 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product 10.4.5 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application 10.4.6 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa Erythropoietin (EPO) Drugs Market 10.4.6.1.1 South Africa Erythropoietin (EPO) Drugs Market by Drug 10.4.6.1.2 South Africa Erythropoietin (EPO) Drugs Market by Product 10.4.6.1.3 South Africa Erythropoietin (EPO) Drugs Market by Application 10.4.6.2 Saudi Arabia Erythropoietin (EPO) Drugs Market 10.4.6.2.1 Saudi Arabia Erythropoietin (EPO) Drugs Market by Drug 10.4.6.2.2 Saudi Arabia Erythropoietin (EPO) Drugs Market by Product 10.4.6.2.3 Saudi Arabia Erythropoietin (EPO) Drugs Market by Application 10.4.6.3 U.A.E Erythropoietin (EPO) Drugs Market 10.4.6.3.1 U.A.E Erythropoietin (EPO) Drugs Market by Drug 10.4.6.3.2 U.A.E Erythropoietin (EPO) Drugs Market by Product 10.4.6.3.3 U.A.E Erythropoietin (EPO) Drugs Market by Application 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America Erythropoietin (EPO) Drugs Market Overview 10.5.2 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis 10.5.3 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug 10.5.4 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product 10.5.5 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application 10.5.6 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil Erythropoietin (EPO) Drugs Market 10.5.6.1.1 Brazil Erythropoietin (EPO) Drugs Market by Drug 10.5.6.1.2 Brazil Erythropoietin (EPO) Drugs Market by Product 10.5.6.1.3 Brazil Erythropoietin (EPO) Drugs Market by Application 10.5.6.2 Argentina Erythropoietin (EPO) Drugs Market 10.5.6.2.1 Argentina Erythropoietin (EPO) Drugs Market by Drug 10.5.6.2.2 Argentina Erythropoietin (EPO) Drugs Market by Product 10.5.6.2.3 Argentina Erythropoietin (EPO) Drugs Market by Application 11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 12. ERYTHROPOIETIN (EPO) DRUGS MARKET, KEY COMPANY PROFILES 12.1. JOHNSON AND JOHNSON 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. CELLTRION, INC 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. TEVA PHARMACEUTICAL INDUSTRIES LTD 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. AMGEN, INC 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. F. HOFFMAN-LA ROCHE LTD 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. LG LIFE SCIENCES LTD 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. BIOCON LIMITED 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. INTAS PHARMACEUTICALS LTD 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. SUN PHARMACEUTICAL INDUSTRIES LTD 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. DR. REDDY’S LABORATORIES LTD. 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments 13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
The List of Companies
- Johnson & Johnson - Celltrion, Inc - Teva Pharmaceutical Industries Ltd - Amgen, Inc - F. Hoffman-La Roche Ltd. - LG Life Sciences Ltd. - Biocon Limited - Intas Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Dr. Reddy's Laboratories Ltd.
